MDIC is the only public-private partnership (PPP) developed to work with government and industry stakeholders in an effort to advance solutions that promote patient access to innovative medical technologies.

External Evidence Methods Framework Project earns CDRH Regulatory Science Excellence Award

Congratulations to Jithesh Veetil, PhD, awarded The CDRH Regulatory Science Excellence Award for for the External Evidence Methods (EEM) Framework Project. MDIC EEM Framework is a document intended to help stakeholders navigate their way through the nuts and bolts of leveraging external data. Informed by a number of public forums and a survey of medical […]

MDIC’s Patient Advisory Group (PAG) Develops Patient Engagement Survey

MDIC’s Patient Advisory Group (PAG) developed this survey to collect your feedback regarding the processes and mechanisms you use to engage with patients throughout the total product lifecycle (TPLC). NOTE: The focus of the survey is on patient engagement and the use of patient personas in the product development process.  We are not asking for […]

Annual Public Forum Registration Opens!

Early Bird registration is open for the 2022 MDIC Annual Public Forum to be held in Washington, DC, on Tuesday September 13 – our first in-person APF since 2019! Join us for General Sessions on Digital Health, Health Economics & Patient Value, and NESTcc, as well as concurrent sessions across a wide range of topics […]

MDIC Curates:

Industry News from Around the Web

, , ,

Around the Web: Stakeholders seek tweaks to FDA’s voluntary improvement program guidance

Stakeholders seek tweaks to FDA’s voluntary improvement program guidance Regulatory NewsRegulatory News | 08 July 2022 | By Jeff Craven 3044 The US Food and Drug Administration (FDA) has received comments on its draft guidance on engaging…
,

Around the Web: Calidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial of NeuroNova in Patients with Recurrent High-Grade Glioma

LA JOLLA, Calif.--(BUSINESS WIRE)-- Calidi Biotherapeutics, Inc. (Calidi), a clinical-stage biotechnology company that is pioneering allogeneic cell-based platforms to revolutionize oncolytic virus therapies, is pleased to announce that…
© 2022 Medical Device Innovation Consortium. All Rights Reserved.Privacy Policy